Our findings suggest that the SKAP1‐NFATc1‐CXCL8‐NET axis is a novel mechanism underlying colon cancer progression, and that targeting SKAP1 is a potential strategy for colon cancer treatment. The gene discussed is SKAP1; the disease is colonic neoplasm.